These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6310356)

  • 1. Establishment of spontaneously outgrowing lymphoblastoid cell lines with Cyclosporin A.
    von Knebel Doeberitz M; Bornkamm GW; zur Hausen H
    Med Microbiol Immunol; 1983; 172(2):87-99. PubMed ID: 6310356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A routine method for the establishment of permanent growing lymphoblastoid cell lines.
    Neitzel H
    Hum Genet; 1986 Aug; 73(4):320-6. PubMed ID: 3017841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines.
    Bird AG; McLachlan SM; Britton S
    Nature; 1981 Jan; 289(5795):300-1. PubMed ID: 6256660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A.
    Rickinson AB; Rowe M; Hart IJ; Yao QY; Henderson LE; Rabin H; Epstein MA
    Cell Immunol; 1984 Sep; 87(2):646-58. PubMed ID: 6088089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation.
    Lewin N; Aman P; Akerlund B; Gustavsson E; Carenfelt C; Lejdeborn L; Klein G; Klein E
    Immunol Lett; 1990 Oct; 26(1):59-65. PubMed ID: 2177451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A.
    Pelloquin F; Lamelin JP; Lenoir GM
    In Vitro Cell Dev Biol; 1986 Dec; 22(12):689-94. PubMed ID: 3023278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of EBV-Infected Lymphoblastoid Cell Lines.
    Nagy N
    Methods Mol Biol; 2017; 1532():57-64. PubMed ID: 27873266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a B-lymphoblastoid cell line infected with Epstein-Barr-related virus from a cynomolgus monkey (Macaca fascicularis).
    Fujimoto K; Terato K; Miyamoto J; Ishiko H; Fujisaki M; Cho F; Honjo S
    J Med Primatol; 1990; 19(1):21-30. PubMed ID: 2160013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of Epstein-Barr virus (EBV) genes BBRF3, BILF1, and BMRF2 in EBV-transformed lymphoblastoid lines from ataxia-telangiectasia patients.
    Becker Y; Tabor E; Asher Y
    Leukemia; 1988 Dec; 2(12 Suppl):178S-191S. PubMed ID: 2848995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
    Aguirre AJ; Robertson ES
    J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.
    Cuomo L; Trivedi P; de Campos-Lima PO; Zhang QJ; Ragnar E; Klein G; Masucci MG
    Mol Immunol; 1993 Apr; 30(5):441-50. PubMed ID: 7681932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
    Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G
    Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of enhancement of Epstein-Barr virus-induced transformation of peripheral blood lymphocytes by a tumor promoter, TPA, with special reference to lowering of cytotoxicity of T cells.
    Harada S; Katsuki T; Yamamoto H; Hinuma Y
    Int J Cancer; 1981 May; 27(5):617-23. PubMed ID: 6270019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
    Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
    J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV)-lymphoid cell interactions. I. Quantification of EBV particles required for the membrane immunofluorescence assay and the comparative expression of EBV receptors on different human B, T and null cell lines.
    Patel P; Menezes J
    J Gen Virol; 1981 Mar; 53(Pt 1):1-11. PubMed ID: 6268736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of Epstein-Barr virus growth-transformed lymphoblastoid cell lines.
    Hui-Yuen J; McAllister S; Koganti S; Hill E; Bhaduri-McIntosh S
    J Vis Exp; 2011 Nov; (57):. PubMed ID: 22090023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell growth effects of Epstein-Barr virus leader protein.
    Allan GJ; Inman GJ; Parker BD; Rowe DT; Farrell PJ
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1547-51. PubMed ID: 1318948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced frequency of spontaneous B cell lines from Epstein-Barr virus (EBV) seropositive donors 80 years and older.
    Rangan SR; Armatis P
    Exp Gerontol; 1991; 26(6):541-7. PubMed ID: 1666055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ
    J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A-type and B-type Epstein-Barr virus differ in their ability to spontaneously enter the lytic cycle.
    Buck M; Cross S; Krauer K; Kienzle N; Sculley TB
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():441-445. PubMed ID: 10073706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.